Thrombocytosis

Results: 88



#Item
51HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NPLATE safely and effectively. See full prescribing information for NPLATE. Nplate® (romiplostim), for subcutaneous

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NPLATE safely and effectively. See full prescribing information for NPLATE. Nplate® (romiplostim), for subcutaneous

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-11-06 14:38:12
52Rx only  DROXIA® (hydroxyurea capsules, USP) WARNING Treatment of patients with DROXIA may be complicated by severe, sometimes lifethreatening, adverse effects. DROXIA should be administered under the supervision of a

Rx only DROXIA® (hydroxyurea capsules, USP) WARNING Treatment of patients with DROXIA may be complicated by severe, sometimes lifethreatening, adverse effects. DROXIA should be administered under the supervision of a

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-01-30 16:15:55
53_______________  HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JAKAFI safely and effectively. See full prescribing information for JAKAFI.

_______________ HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use JAKAFI safely and effectively. See full prescribing information for JAKAFI.

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-11-26 15:13:16
54CMDh BEST PRACTICE GUIDE FOR TRANSITIONAL ARRANGEMENTS FOR PSUR WORK SHARING - November 2012

CMDh BEST PRACTICE GUIDE FOR TRANSITIONAL ARRANGEMENTS FOR PSUR WORK SHARING - November 2012

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2013-12-02 10:42:12
55NDA[removed]S-010 Page 3 AGRYLIN® (anagrelide hydrochloride) Capsules Rx only

NDA[removed]S-010 Page 3 AGRYLIN® (anagrelide hydrochloride) Capsules Rx only

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 15:46:55
56HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PROMACTA safely and effectively. See full prescribing information for PROMACTA.  ----------------------- DOSAGE AND

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PROMACTA safely and effectively. See full prescribing information for PROMACTA. ----------------------- DOSAGE AND

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-02-11 12:04:25
57AGRYLIN® (anagrelide hydrochloride) Capsules Rx only

AGRYLIN® (anagrelide hydrochloride) Capsules Rx only

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-02-10 12:18:07
58MEMORANDUM  DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH

MEMORANDUM DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-11-17 09:59:07
59AGRYLIN® (anagrelide hydrochloride) Capsules Rx only

AGRYLIN® (anagrelide hydrochloride) Capsules Rx only

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-12-02 14:39:35
60Use of Molecular Testing to Identify a Cluster of Patients with Polycythemia Vera in Eastern Pennsylvania

Use of Molecular Testing to Identify a Cluster of Patients with Polycythemia Vera in Eastern Pennsylvania

Add to Reading List

Source URL: www.atsdr.cdc.gov

Language: English - Date: 2011-09-27 10:28:27